Sugano, Teppei
Yoshida, Masayuki
Masuda, Mari
Ono, Makiko
Tamura, Kenji
Kinoshita, Takayuki
Tsuda, Hitoshi
Honda, Kazufumi
Gemma, Akihiko
Yamada, Tesshi
Article History
Received: 7 July 2019
Revised: 8 January 2020
Accepted: 10 March 2020
First Online: 8 April 2020
Ethics approval and consent to participate
: The use of human samples for this study was reviewed and approved by the Institutional Review Board (IRB) of the National Cancer Center (Tokyo, Japan) [Authorisation numbers: 2014-381 (Japanese cohort) and 2016-017 (US cohort)] and conducted in accordance with the Declaration of Helsinki. The IRB waived the requirement for obtaining new informed consent to this study.
: No individually identifiable data are presented.
: The datasets generated and/or analysed during the present study are not publicly available, but anonymised versions may be available from the corresponding author on reasonable request.
: The authors declare no competing interests.
: This study was supported by the National Cancer Center Research and Development Fund (26-A-13 and 26-A-5 to T. Yamada), the Acceleration Transformative Research for Medical Innovation (ACT-MS) program of the Japan Agency for Medical Research and Development (AMED) (16im0210804h0001 to T. Yamada), the Kobayashi Foundation for Cancer Research (to T. Yamada), a KAKENHI Grant-in-Aid for Challenging Exploratory Research (16K14627 to M. Masuda), a Grant-in Aid for Scientific Research (B) (17H03603 to M. Masuda) from the Japan Society for the Promotion of Science (JSPS), a Cancer Research Grant from the Foundation for Promotion of Cancer Research in Japan (to M. Masuda), and a Research Grant from the Princess Takamatsu Cancer Research Fund (to M. Masuda).